Jalink Maarten B, Burger Berend B, Kalmann Rachel
Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.
Case Rep Ophthalmol. 2022 Oct 11;13(3):789-792. doi: 10.1159/000526225. eCollection 2022 Sep-Dec.
The aim of this paper was to report the case of a patient with orbital inflammation and dacryoadenitis after COVID-19 vaccination. During the COVID-19 pandemic, we noticed an increase of post-viral syndromes, both linked to infection and to vaccination. A 53-year-old male presented with proptosis, chemosis, hypotropia, and ophthalmoplegia of the right eye, 1 day after his COVID-19 booster shot. Anecdotally, he suffered similar symptoms after his initial two vaccinations. Idiopathic orbital inflammation and dacryoadenitis were diagnosed, and the patient was successfully treated with oral steroids. Orbital inflammation and dacryoadenitis after infection or vaccination are no new entities, but due to the scale of the current pandemic and the associated vaccination programs, these rare ocular diseases could be encountered more often.
本文旨在报告1例新型冠状病毒肺炎（COVID-19）疫苗接种后出现眼眶炎症和泪腺炎的患者。在COVID-19大流行期间，我们注意到与感染和疫苗接种相关的病毒后综合征有所增加。一名53岁男性在接种COVID-19加强针后1天，出现右眼眼球突出、球结膜水肿、下斜视和眼球运动障碍。据其本人讲述，在最初两次接种疫苗后他也出现过类似症状。诊断为特发性眼眶炎症和泪腺炎，该患者接受口服类固醇治疗后痊愈。感染或接种疫苗后出现眼眶炎症和泪腺炎并非新现象，但鉴于当前大流行的规模以及相关疫苗接种计划，这些罕见的眼部疾病可能会更频繁地出现。
